Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
08/2001
08/08/2001EP1121378A1 A process for the preparation of a thrombus imaging agent
08/08/2001EP1121196A2 Porous device
08/08/2001EP0837878B1 Antitumor proteins from rana pipiens oocytes
08/08/2001EP0820463A4 Igf-i purification process
08/08/2001CN1307589A Seeding crystals for the preparation of peptides or proteins
08/07/2001US6271345 For synthesis of organic compounds, combinatorial chemistry
08/07/2001US6271195 Aminimide-containing molecules and materials as molecular recognition agents
08/07/2001US6271037 Method and product for the sequence determination of peptides using a mass spectrometer
08/07/2001CA2044746C Polypeptide compound and a process for preparation thereof
08/02/2001WO2001055449A1 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055440A1 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055213A2 Process for solubilizing glucagon-like peptide 1 (glp-1) compounds
08/02/2001WO2001055175A2 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides
08/02/2001WO2001055174A2 Universal procedure for refolding recombinant proteins
08/02/2001WO2001055091A1 Solid-supported process for making n-substituted peptide mimetic compounds
08/02/2001WO2001018059A3 Congener independent detection of microcystin and nodularin congeners
08/02/2001WO2001005808A3 In vitro selection and optional identification of polypeptides using solid support carriers
08/02/2001WO2000069887A3 Rapid dehydration of proteins
08/02/2001WO2000064483A3 Releasable linkage and compositions containing same
08/02/2001CA2396920A1 Process for solubilizing glucagon-like peptide 1 (glp-1) compounds
08/02/2001CA2395676A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2393941A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2366828A1 Preparation and use of polymers crosslinked with tyrosine-containing peptides
08/01/2001EP1120469A2 Method for actively transporting DNA
08/01/2001EP1120425A1 Process for eliminating n-terminal methionine
08/01/2001EP1120157A2 Self-addressable electronic device
08/01/2001EP1120156A2 Method of electronically controlled hybridization of DNA
08/01/2001EP1120155A2 Method for combinatorial synthesis of a biopolymer
08/01/2001EP1119583A1 Crystals of the alpha 1 beta 1 integrin i-domain and their use
08/01/2001EP1119528A2 Chemical constructs and their uses
08/01/2001EP0656946B1 Immunoglobulins devoid of light chains
08/01/2001EP0649434B1 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
08/01/2001EP0590012B1 Mutant proteolytic enzymes from bacillus
08/01/2001CN1306439A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
08/01/2001CN1306089A Structure and purification of venin-class thrombase for preventing and curing thrombotic diseases
08/01/2001CN1306086A Process for preparing recombinant cumic kinase and its bioactivity
08/01/2001CN1306008A Conjugate of Lidamycin with active fragment of monoclonal antibody
08/01/2001CN1306007A Dry cell factor
08/01/2001CN1069062C Use of follicle-stimulating hormone
07/2001
07/31/2001US6269312 Apparatus and method for automated protein design
07/31/2001US6268487 Purification of biologically active peptides from milk
07/31/2001US6268486 Contacting mixture of polypeptide and impurities with specific monoclonal antibody so that binding occurs, desorbing polypeptide from antibody, and collecting polypeptide; immunoaffinity chromatography
07/31/2001US6268339 Lanthionine bridged peptides
07/31/2001US6268218 Method for sensing and processing fluorescence data from multiple samples
07/31/2001US6268207 Resolution of enantiomers from a mixture of (1r,2s)/(1s,2s)-1-amino-2-vinylcyclopropyl carboxylic acid methyl ester comprising the step of treating said mixture with an esterase to obtain the corresponding (1r,2s) enantiomer
07/31/2001US6268158 Generating thermal denaturation curve
07/31/2001US6268053 Blend of macromolecule and polymer
07/31/2001US6267973 Ectoin and ectoin derivatives as moisturizers in cosmetics
07/31/2001CA2276548C Improved methods for the preparation of endotoxin-binding proteins
07/31/2001CA2018511C Process for the preparation of purified albumin solutions
07/26/2001WO2001053333A1 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins
07/26/2001WO2001053330A2 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
07/26/2001WO2001053329A1 Process for the purification of antithrombin-iii
07/26/2001WO2001053328A1 Process for the purification of antothrombin-iii
07/26/2001WO2001053327A2 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
07/26/2001WO2001053325A2 Method of affinity purifying proteins using modified bis-arsenical fluorescein
07/26/2001WO2001053243A1 Novel arylpropionaldehyde derivatives and production and use of the same
07/26/2001WO2001052612A2 Method for isolating proteins or protein and nucleic acid associations, and resulting complexes of particles and proteins
07/26/2001WO2001008792A3 Charged filtration membranes and uses therefor
07/26/2001WO2000067894A3 Methods of software driven flow sorting for reiterative synthesis cycles
07/26/2001CA2743326A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same
07/26/2001CA2412536A1 Method for isolating proteins or protein and nucleic acid associations, and resulting complexes of particles and proteins, reagents and applications
07/26/2001CA2398605A1 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins
07/26/2001CA2395594A1 Process for the purification of antithrombin-iii
07/26/2001CA2395489A1 Process for the purification of antothrombin-iii
07/25/2001EP1117999A1 Characterising polypeptides through cleavage and mass spectrometry
07/25/2001EP1117996A2 Method and device for producing and/or analyzing biochemical reaction supporting materials
07/25/2001EP1117693A2 Intein mediated peptide ligation
07/25/2001EP1117678A1 Solid phase synthesis, whereby the solid phase consists of two different substrates
07/25/2001EP1117677A1 Ligand presenting assembly (lpa), method of preparation and uses thereof
07/25/2001EP1117478A2 Support for a method for determining an analyte and a method for producing the support
07/25/2001EP1117439A1 Methods for identification, diagnosis, and treatment of breast cancer
07/25/2001EP1117325A1 Apparatus for examining a patient by means of light
07/25/2001EP0906333B1 Substrates and inhibitors of proteolytic enzymes
07/25/2001EP0577605B1 G protein-coupled glutamate receptors
07/25/2001CN1305589A Improved immunodiagnostic assays using reducing agents
07/25/2001CN1305490A Improved processing for preparing schift base adducts of amines with i(o)-hydroxy aldehydes and compositions of matter based thereon
07/24/2001US6266622 Nuclear receptor ligands and ligand binding domains
07/24/2001US6265590 New protected amino acid derivatives useful for peptide synthesis
07/24/2001US6265552 Immobilization of protein on surface; transform cell with vector, culture cells, isolate immobilized fusion protein from prepared surface
07/24/2001US6265536 Cyclic hexapeptides having antibiotic activity
07/24/2001US6265534 Superpotent calcitonin analogs having greatly increased hypocalcemic action in vivo
07/24/2001US6265376 Insecticidal plectoxins from plectreurys tristis
07/24/2001US6264919 Restoring fluorescence; adding biocompatible solvent
07/24/2001CA2092652C Antiherpes peptide derivatives having a ureido n-terminus
07/24/2001CA2065299C Direct radiolabeling of antibodies and other proteins with technetium or rhenium
07/24/2001CA2058676C Process for isolating human albumin from supernatant iv, in particular iv-4, or from cohn's fraction v or from an analogous supernatant or fraction
07/24/2001CA2057014C Process for purification of polypeptide
07/24/2001CA2027936C Cyclic anti-aggregatory peptides
07/19/2001WO2001051506A2 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides
07/19/2001WO2001051505A1 Nα-2-(4-NITROPHENYLSULFONYL)ETHOXYCARBONYL-AMINO ACID FLUORIDES AND PROCESS FOR THE PREPARATION THEREOF
07/19/2001WO2001051011A2 Condensation products of proteins, whereby azelaic acid is used
07/19/2001WO2001005757A3 Process for the deprotection of protected thiols
07/19/2001US20010008881 Method for the augmentation of gene expression
07/18/2001EP1116020A1 Method for separation of macromolecules
07/18/2001EP1115888A2 Water-soluble luminescent quantum dots and bioconjugates thereof
07/18/2001EP1115845A2 Fibrils
07/18/2001EP1115739A1 Auxiliary for amide bond formation
07/18/2001EP1115738A1 Synthesis of cyclic peptides
07/18/2001EP1115424A1 Method and measuring device for determining a plurality of analytes in a sample